Significance of serum osteoprotegerin and receptor activator of nuclear factor κB ligand in Japanese prostate cancer patients with bone metastasis

• KAMIYA Naoto

  Department of Urology, Toho University Sakura Medical Center

• SUZUKI Hiroyoshi

  Department of Urology, Toho University Sakura Medical Center

• ENDO Takumi

  Department of Urology, Toho University Sakura Medical Center

• TAKANO Makoto

  Department of Urology, Toho University Sakura Medical Center

• YANO Masashi

  Department of Urology, Toho University Sakura Medical Center

• NAOI Makito

  Department of Urology, Toho University Sakura Medical Center

• KAWAMURA Koji

  Department of Urology, Graduate School of Medicine, Chiba University

• IMAMOTO Takashi

  Department of Urology, Graduate School of Medicine, Chiba University

• TAKANAMI Masaharu

  Department of Urology, Toho University Sakura Medical Center

• ICHIKAWA Tomohiko

  Department of Urology, Graduate School of Medicine, Chiba University

Journal

• Int. J. Clin. Oncol.

  Int. J. Clin. Oncol. 16 (4), 366-372, 2011-08-01

Keywords

• Prostate cancer
• Osteoprotegerin
• Receptor activator of nuclear factor κB ligand
• Bone metastasis

Details

• CRID: 1573387449849912960
• NII Article ID: 10029527657
• NII Book ID: AA11086579
• ISSN: 13419625
• Text Lang: en
• Data Source:
  • CiNii Articles